The latest price target for Ingevity (NYSE:NGVT) was reported by BMO Capital on August 5, 2024. The analyst firm set a price target for $42.00 expecting NGVT to rise to within 12 months (a possible 7.44% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Ingevity (NYSE:NGVT) was provided by BMO Capital, and Ingevity maintained their market perform rating.

The last upgrade for Ingevity Corp happened on April 22, 2024 when Jefferies raised their price target to $62. Jefferies previously had a hold for Ingevity Corp.

The last downgrade for Ingevity Corp happened on October 3, 2023 when Loop Capital changed their price target from $62 to $53 for Ingevity Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingevity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingevity was filed on August 5, 2024 so you should expect the next rating to be made available sometime around August 5, 2025.

While ratings are subjective and will change, the latest Ingevity (NGVT) rating was a maintained with a price target of $45.00 to $42.00. The current price Ingevity (NGVT) is trading at is $39.09, which is out of the analyst’s predicted range.